M&A Deal Summary |
|
---|---|
Date | 2021-06-18 |
Target | Altan Pharma |
Sector | Life Science |
Buyer(s) | Ethypharm |
Sellers(s) | Malin |
Deal Type | Divestiture |
Advisor(s) | Jefferies (Financial) |
SEARCH BY
Try For Free 7-Day Free Trial
Category | Company |
---|---|
Founded | 1977 |
Sector | Life Science |
Employees | 810 |
Revenue | 186M EUR (2015) |
Ethypharm is a Drug Delivery System (DDS) company. The company develops and manufactures medicinal products specialising in controlled release products. Drug Delivery Systems provide major benefits including improving the drug efficacy, enhancing patient compliance and comfort, extending the life cycle of existing drugs, and reducing the total cost of treatment. Ethypharm was founded in 1977 and is based in SaintCloud, France.
DEAL STATS | # |
---|---|
Overall | 3 of 3 |
Sector (Life Science) | 2 of 2 |
Type (Divestiture) | 1 of 1 |
Country (Ireland) | 1 of 1 |
Year (2021) | 1 of 1 |
DATE | TARGET | DEAL TYPE | VALUE |
---|---|---|---|
2017-01-19 |
Martindale Pharmaceuticals
Brentwood, United Kingdom Martindale Pharmaceuticals Ltd. is a niche manufacturer and supplier of specialty pharmaceutical products and services, including Unlicensed medicines (‘Specials’), injectables, pre-filled syringes and oral solutions. Martindale has a diverse portfolio of over 200 licensed compounds and a proprietary database of 30,000 formulations for Specials. Martindale’s in-house expertise covers the full product lifecycle from formulation, to product development, registration and licensing, manufacturing and full quality monitoring and testing. |
Buy | - |
Category | Company |
---|---|
Founded | 2014 |
Sector | Life Science |
Employees | 255 |
Revenue | 41M EUR (2020) |
Malin is a globally operating life sciences company. Malin was founded in 2014 and is based in Dublin, Ireland.
DEAL STATS | # |
---|---|
Overall | 5 of 6 |
Sector (Life Science) | 4 of 4 |
Type (Divestiture) | 2 of 3 |
Country (Ireland) | 2 of 3 |
Year (2021) | 2 of 2 |
DATE | TARGET | DEAL TYPE | VALUE |
---|---|---|---|
2021-02-04 |
Immunocore
Abingdon, United Kingdom Immunocore is a late-stage biotechnology company focused on the development of a novel class of TCR bispecific immunotherapies called ImmTAX Immune mobilizing monoclonal TCRs Against X disease designed to treat a broad range of diseases, including cancer, infectious and autoimmune. Immunocore was founded in 1999 and is based in Abingdon, United Kingdom. |
Sell | - |
DATE | TARGET | DEAL TYPE | VALUE |
---|---|---|---|
2023-05-23 |
Cilatus
Dun Laoghaire, Ireland Cilatus is a provider in the management and services of CMC Development, CMC Regulatory Affairs, Quality Management, Engineering, Validation/Qualification and Manufacturing for biological products. Cilatus was founded in 2014 and is based in Dun Laoghaire, Ireland. |
Sell | - |